Next generation sequencing and tumor mutation profiling: Are we ready for routine use in the oncology clinic?.
Times cited: 24
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer.
Clinical Cancer Research.
Times cited: 296